Surface plants accredited by three or more regulators (FDA, EDQM, WHO-PQ, ANVISA, EMA). The global-supply-ready cohort, joined to molecule footprint.
Twenty plants in the live register hold active accreditations from three or more regulators. Alivira Animal Health (IN, Visakhapatnam), Ami Lifesciences (IN, Vadodara), and Nordmark Pharma (DE) carry FDA + EDQM + WHO-PQ overlap. Fresenius Kabi Austria and Farmhispania (ES) add ANVISA to the mix. The cohort is the global-supply-ready pool: plants that can serve US, EU, and access-market lanes from the same facility.
| # | Plant | Region | Regulators | Recent inspection | Molecule footprint |
|---|---|---|---|---|---|
| 1 | Alivira Animal Health | IN · Visakhapatnam | 3 regulators | FDA + EDQM + WHO-PQ | NAI |
| 2 | Ami Lifesciences | IN · Vadodara | 3 regulators | FDA + EDQM + WHO-PQ | NAI |
| 3 | Nordmark Pharma | DE · Uetersen | 3 regulators | FDA + EDQM + EMA | NAI |
| 4 | Fresenius Kabi Austria | AT · Linz | 3 regulators | FDA + EDQM + ANVISA | NAI |
| 5 | Farmhispania | ES · Madrid | 3 regulators | FDA + EDQM + EMA | NAI |
| 6 | Chongqing Carelife | CN · Chongqing | 3 regulators | FDA + EDQM + WHO-PQ | VAI |
| 7 | Shandong New Time | CN · Shandong | 3 regulators | FDA + EDQM + ANVISA | NAI |
| 8 | Shaoxing Jingxin | CN · Shaoxing | 3 regulators | FDA + EDQM + WHO-PQ | VAI |
Default is three or more active regulators per plant. Buyers can tune to four-plus or to specific regulator combinations.
Each plant's regulator coverage is computed from the canonical accreditation catalog. Inspection class and molecule footprint join at the schema layer.
Citation-anchored brief with the qualifying plants, regulator chips, inspection class, and a molecule-footprint summary.
A plant accredited by FDA + EDQM + WHO-PQ can ship into US, EU, and access markets from the same facility. The buyer qualifies once and serves three regulatory geographies.
Plants that maintain three or more active accreditations are signalling sustained quality-system investment. The regulator-coverage chip is a leading indicator of audit readiness.
Regulator coverage matters only if the plant manufactures relevant molecules. The footprint chip surfaces the matched molecule count per plant for the buyer's portfolio.
Accreditation registers publish monthly. Coverage transitions (lapses, new issuance) propagate on the next refresh; the catalog row carries an as-of timestamp.
A real chat thread in PharmaDB. Type a question, the AI agent runs the tools, the answer lands as a saveable note.
pharmagraph_query Plant cohort · counts by regulator-overlap category, live register 2026.
Multi-regulator accredited plants are the global-supply tier. PharmaDB joins every regulator’s accreditation register to the canonical plant catalog, computes overlap counts, and surfaces the qualifying cohort with inspection class and molecule footprint. The view rests on plant_accreditations joined to plants and inspections. Refresh cadence is monthly.
Three is operationally meaningful: a plant maintaining FDA + EDQM + a third major regulator (WHO-PQ, EMA, ANVISA) demonstrates audit readiness for multi-market commercial supply. Two-regulator plants are common; three-regulator plants are the visible global-supply tier.
Yes. Plants with active GMP certificates from each regulator surface. GMP is the floor; specific product-level certificates (CEP for EU, WHO-PQ for institutional) layer on top. The regulator-overlap count is GMP-anchored unless a buyer opts into product-level filtering.
Monthly. Each regulator's accreditation register publishes on a different cadence (FDA continuous, EDQM monthly, WHO-PQ quarterly, ANVISA continuous). PharmaDB normalises to a monthly catalog refresh; the catalog row carries an as-of timestamp.
Lapsed and suspended accreditations are excluded from the active count by default. The historical view is queryable for diligence work but does not contribute to the multi-regulator chip on the live shortlist.
Counts collapse to the distinct-regulator level. A plant with twenty EDQM CEPs counts EDQM once. The molecule footprint metric surfaces the volume separately for buyers who care about product-level coverage.
Dual-Accredited Plants (FDA + EDQM) is the most common two-regulator combination and gets a dedicated view because of its specific use in trans-Atlantic supply. The tri+ view is the rarer, more demanding tier.
Bring the molecule, the lane, or the supplier you're sourcing this week. The AI agent runs it on PharmaDB in 30 minutes. You keep the brief.